-
-
-
-
-
-
-
Astellas partners with Vir Biotechnology on prostate cancer treatment
-
-
-
-
-
-
-
Vir Biotechnology to Provide Corporate Update and Report Third Quarter 2025 Financial Results on November 5, 2025
-
-
-
-
-
-
-
Brii Biosciences Provides Corporate Update and Reports Full-Year 2024 Financial Results
-
-
-
-
-
-
-
Vir Biotechnology to Provide Business Update and Report Third Quarter 2024 Financial Results on October 31, 2024
-
-
-
-
-
-
-
Vir Biotechnology Reports Second Quarter 2024 Financial Results and Announces Strategic Restructuring to Prioritize Clinical-Stage Pipeline Opportunities
-
-
-
-
-
-
-
Vir Biotechnology Inc. (VIR) Tops Q4 EPS by 22c, Beats on Revenue
-
-
-
-
-
-
-
Vir Biotechnology Inc. (VIR) Misses Q2 EPS by 25c, misses on revenue
-
1,168,522 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

